This is part of its efforts to popularize science to the General Public and Students who are pursuing science as their career. TNSF attempt to focus on students on higher science as everyone knows
that learning of science at college within the curriculum is not enough to acquire holistic knowledge of science at the appropriate time. Hence, to fill the gap between what students are acquiring through the curriculum and what
it is required, TNSF is planning its activities on higher science to students who are pursuing higher education.
There are currently more than 50 COVID-19 vaccine candidates in trials. WHO is working in collaboration with scientists, business,
and global health organizations through the ACT Accelerator to speed up the pandemic response. When a safe and effective vaccine is found,
COVAX (led by WHO, GAVI and CEPI) will facilitate the equitable access and distribution of these vaccines to protect people in all countries.
People most at risk will be prioritized. While we work towards rolling out a safe and effective vaccine fairly, we must continue the essential
public health actions to suppress transmission and reduce mortality.
Introduction
Sandhya Koushika
Neuroscientist, Associate Professor,
Tata Institute of Fundamental Research, Mumbai
Status of COVID-19 Vaccines
Question & Answer
Sandhya Koushika is an Indian neuroscientist, currently working at the Tata Institute of Fundamental Research, Mumbai. Her main area of interest is regulation of axonal transport within nerve cells. She is a recipient of the International Early Career Award by the Howard Hughes Medical Institute (USA). Koushika earned her B.Sc. and M.Sc. degrees from Maharaja Sayajirao University and received her Ph.D. (Cellular and Molecular Biology) from Brandeis University. Her postdoctoral training was at Washington University. Prior to her current appointment at TIFR, Mumbai, she was a faculty at the National Centre for Biological Sciences, Bangalore.